Spots Global Cancer Trial Database for solid neoplasm

Every month we try and update this database with for solid neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors	NCT02867592	Adrenal Cortica... Alveolar Soft P... Central Nervous... Childhood Clear... Clear Cell Sarc... Ewing Sarcoma Hepatoblastoma Hepatocellular ... Osteosarcoma Recurrent Adren... Recurrent Alveo... Recurrent Clear... Recurrent Ewing... Recurrent Hepat... Recurrent Hepat... Recurrent Kidne... Recurrent Malig... Recurrent Osteo... Recurrent Prima... Recurrent Renal... Recurrent Rhabd... Recurrent Soft ... Recurrent Thyro... Refractory Adre... Refractory Alve... Refractory Clea... Refractory Ewin... Refractory Hepa... Refractory Hepa... Refractory Mali... Refractory Oste... Refractory Prim... Refractory Prim... Refractory Rena... Refractory Rhab... Refractory Soft... Refractory Thyr... Refractory Wilm... Renal Cell Carc... Rhabdomyosarcom... Soft Tissue Sar... Solid Neoplasm Thyroid Gland M... Wilms Tumor	Cabozantinib Cabozantinib S-... Pharmacological...	2 Years - 30 Years	National Cancer Institute (NCI)
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors	NCT02897375	Solid Neoplasm Stage III Pancr... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Non-Sm... Stage IVA Pancr... Stage IVB Pancr... Sarcoma Colorectal Canc... Head and Neck C... Cancer of Unkno... Bladder Cancer Ovarian Cancer	Carboplatin Cisplatin Palbociclib	18 Years -	Emory University
Veliparib With or Without Mitomycin C in Treating Patients With Metastatic, Unresectable, or Recurrent Solid Tumors	NCT01017640	Solid Neoplasm	Laboratory Biom... Mitomycin Veliparib	18 Years -	National Cancer Institute (NCI)
TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors	NCT02650635	Colorectal Aden... Metastatic Panc... Recurrent Breas... Recurrent Color... Recurrent Melan... Recurrent Non-S... Recurrent Pancr... Recurrent Renal... Solid Neoplasm Stage IV Breast... Stage IV Non-Sm... Stage IV Renal ... Stage IV Skin M... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr...	Cyclophosphamid... Laboratory Biom... Pegfilgrastim Pharmacological... TLR8 Agonist VT...	18 Years -	Mayo Clinic
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors	NCT02897375	Solid Neoplasm Stage III Pancr... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Non-Sm... Stage IVA Pancr... Stage IVB Pancr... Sarcoma Colorectal Canc... Head and Neck C... Cancer of Unkno... Bladder Cancer Ovarian Cancer	Carboplatin Cisplatin Palbociclib	18 Years -	Emory University
UWCCC Molecular Tumor Board Registry	NCT03023202	Hematologic Neo... Solid Neoplasm	PMMTB (Precisio...	18 Years -	University of Wisconsin, Madison
Tivantinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery	NCT01749384	Solid Neoplasm	Bevacizumab Laboratory Biom... Pharmacological... Tivantinib	18 Years -	National Cancer Institute (NCI)
Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma	NCT00740805	Ann Arbor Stage... Ann Arbor Stage... Solid Neoplasm	Cyclophosphamid... Doxorubicin Hyd... Laboratory Biom... Pharmacological... Veliparib	18 Years -	National Cancer Institute (NCI)
Study in Advanced Solid Tumors	NCT01099358	Solid Tumor	Cetuximab Cisplatin 5 - Fluorouraci...	18 Years -	Eli Lilly and Company
Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases	NCT02360215	Cognitive Impai... Metastatic Mali... Solid Neoplasm	Whole brain rad... Memantine Whole brain rad...	18 Years -	NRG Oncology
Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases	NCT02360215	Cognitive Impai... Metastatic Mali... Solid Neoplasm	Whole brain rad... Memantine Whole brain rad...	18 Years -	NRG Oncology
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors	NCT02142803	Adult Glioblast... Endometrial Cle... Endometrial Ser... Ovarian Clear C... Ovarian Endomet... Ovarian Mucinou... Ovarian Serous ... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Recurrent Uteri... Solid Neoplasm Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar...	Bevacizumab Laboratory Biom... Pharmacological... Sapanisertib	18 Years -	National Cancer Institute (NCI)
Geriatric Assessment in Predicting Chemotherapy Toxicity and Vulnerabilities in Older Patients With Cancer	NCT02517034	Solid Neoplasm	Comprehensive G... Quality-of-Life... Questionnaire A... Survey Administ...	65 Years -	City of Hope Medical Center
TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors	NCT02650635	Colorectal Aden... Metastatic Panc... Recurrent Breas... Recurrent Color... Recurrent Melan... Recurrent Non-S... Recurrent Pancr... Recurrent Renal... Solid Neoplasm Stage IV Breast... Stage IV Non-Sm... Stage IV Renal ... Stage IV Skin M... Stage IVA Color... Stage IVA Pancr... Stage IVB Color... Stage IVB Pancr...	Cyclophosphamid... Laboratory Biom... Pegfilgrastim Pharmacological... TLR8 Agonist VT...	18 Years -	Mayo Clinic
Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY	NCT04060849	Hematopoietic a... Malignant Solid... Solid Neoplasm	Nozin Best Practice	18 Years -	Fred Hutchinson Cancer Center
Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia	NCT03834961	Central Nervous... Infantile Fibro... Recurrent Acute... Refractory Acut... Solid Neoplasm	Larotrectinib S...	- 30 Years	Children's Oncology Group
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF	NCT03604315	Breast Carcinom... Fallopian Tube ... Ovarian Carcino... Primary Periton... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Solid Neoplasm	Computed Tomogr... Computed Tomogr... Fludeoxyglucose... Fluorine F 18 F... Positron Emissi... Positron Emissi...	18 Years -	M.D. Anderson Cancer Center
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors	NCT02142803	Adult Glioblast... Endometrial Cle... Endometrial Ser... Ovarian Clear C... Ovarian Endomet... Ovarian Mucinou... Ovarian Serous ... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Recurrent Uteri... Solid Neoplasm Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar...	Bevacizumab Laboratory Biom... Pharmacological... Sapanisertib	18 Years -	National Cancer Institute (NCI)
Veliparib With or Without Mitomycin C in Treating Patients With Metastatic, Unresectable, or Recurrent Solid Tumors	NCT01017640	Solid Neoplasm	Laboratory Biom... Mitomycin Veliparib	18 Years -	National Cancer Institute (NCI)
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF	NCT03604315	Breast Carcinom... Fallopian Tube ... Ovarian Carcino... Primary Periton... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Solid Neoplasm	Computed Tomogr... Computed Tomogr... Fludeoxyglucose... Fluorine F 18 F... Positron Emissi... Positron Emissi...	18 Years -	M.D. Anderson Cancer Center
Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY	NCT04060849	Hematopoietic a... Malignant Solid... Solid Neoplasm	Nozin Best Practice	18 Years -	Fred Hutchinson Cancer Center
Tivantinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery	NCT01749384	Solid Neoplasm	Bevacizumab Laboratory Biom... Pharmacological... Tivantinib	18 Years -	National Cancer Institute (NCI)
Movement Tracking Devices to Monitor Physical Activity in Patients Undergoing Chemotherapy	NCT03098277	Solid Neoplasm	Accelerometer Laboratory Biom... Physical Activi... Telephone-Based...	18 Years -	University of Southern California
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors	NCT02897375	Solid Neoplasm Stage III Pancr... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Non-Sm... Stage IVA Pancr... Stage IVB Pancr... Sarcoma Colorectal Canc... Head and Neck C... Cancer of Unkno... Bladder Cancer Ovarian Cancer	Carboplatin Cisplatin Palbociclib	18 Years -	Emory University
A Study in Advanced Solid Tumors	NCT01063075	Solid Tumor	Cetuximab Carboplatin 5 - FU	18 Years -	Eli Lilly and Company
Tipifarnib and Erlotinib Hydrochloride in Treating Patients With Advanced Solid Tumors	NCT00085553	Solid Neoplasm	Erlotinib Hydro... Laboratory Biom... Pharmacological... Tipifarnib	18 Years -	National Cancer Institute (NCI)
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord	NCT02713269	Malignant Diges... Metastatic Head... Metastatic Kidn... Metastatic Mali... Metastatic Mali... Metastatic Mela... Prostate Carcin... Sarcoma Solid Neoplasm Spinal Cord Com... Stage IV Breast... Stage IV Lung N... Thyroid Gland C...	Computed Tomogr... Quality-of-Life... Questionnaire A... Stereotactic Ra... Thermal Ablatio...	18 Years -	M.D. Anderson Cancer Center
Study in Advanced Solid Tumors	NCT01099358	Solid Tumor	Cetuximab Cisplatin 5 - Fluorouraci...	18 Years -	Eli Lilly and Company
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues	NCT04147494	Breast Carcinom... Colon Carcinoma Esophageal Carc... Gastric Carcino... Head and Neck C... Kidney Carcinom... Lung Carcinoma Ovarian Carcino... Pancreatic Carc... Solid Neoplasm Uterine Corpus ...	Computed Tomogr... Gallium Ga 68 F... Gallium Ga 68-l... Positron Emissi... 18F-FDG	18 Years -	Jonsson Comprehensive Cancer Center
Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia	NCT00503854	Fatigue Febrile Neutrop... Solid Neoplasm	Questionnaire	18 Years -	M.D. Anderson Cancer Center
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations	NCT02646319	Advanced Malign... Cervical Squamo... Endometrial Car... Malignant Uteri... Recurrent Bladd... Recurrent Breas... Recurrent Cervi... Recurrent Head ... Recurrent Malig... Recurrent Ovari... Recurrent Prost... Recurrent Renal... Solid Neoplasm Stage III Bladd... Stage III Prost... Stage III Renal... Stage IIIA Brea... Stage IIIA Cerv... Stage IIIA Ovar... Stage IIIB Brea... Stage IIIB Cerv... Stage IIIB Ovar... Stage IIIC Brea... Stage IIIC Ovar... Stage IV Breast... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IVA Bladd... Stage IVA Cervi... Stage IVB Bladd... Stage IVB Cervi...	Laboratory Biom... Nanoparticle Al... Quality-of-Life...	18 Years -	Mayo Clinic
Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors	NCT01552356	Solid Neoplasm	Laboratory Biom... Pazopanib Hydro... Pharmacological...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: